French Glendon E. III's Form 4 filing
Pulmonx Corp (LUNG) · filed Mar 5, 2024
- Accession no.
- 0001415889-24-006829
- Filed
- Mar 5, 2024
- Trade date
- Mar 1, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $63.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| French Glendon E. IIICIK 0001805624 | Director, Officer (PRESIDENT AND CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | SSaleDisposed | −1,189 | $9.06 | −$10,772.34 | 1,122,523 | Direct | |
| Mar 1, 2024 | Common Stock | SSaleDisposed | −1,818 | $9.06 | −$16,471.08 | 1,120,705 | Direct | |
| Mar 1, 2024 | Common Stock | SSaleDisposed | −3,947 | $9.06 | −$35,759.82 | 1,116,758 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.